Zhejiang Hisoar Pharmaceutical Co Ltd Total Liabilities
Zhejiang Hisoar Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has total liabilities worth CN¥2.17 Billion CNY (≈ $317.08 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Zhejiang Hisoar Pharmaceutical Co Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)
Total liabilities of Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2024. This chart illustrates how Zhejiang Hisoar Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Zhejiang Hisoar Pharmaceutical Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Zhejiang Hisoar Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Hisoar Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fangda Special Steel Technology Co Ltd
SHG:600507
|
China | CN¥16.17 Billion |
|
Beijing Bei Mo Gao Ke Friction Mate
SHE:002985
|
China | CN¥918.30 Million |
|
Bega Cheese Ltd
AU:BGA
|
Australia | AU$1.22 Billion |
|
Lotte Chemical Corp
KO:011170
|
Korea | ₩13.78 Trillion |
|
Shanxi Lanhua Sci-Tech Venture Co Ltd
SHG:600123
|
China | CN¥21.48 Billion |
|
Shenzhen Batian Ecotypic Engineering Co Ltd
SHE:002170
|
China | CN¥2.05 Billion |
|
Triangle Tyre Co Ltd
SHG:601163
|
China | CN¥5.88 Billion |
|
JSL Construction & Development Co Ltd
TW:2540
|
Taiwan | NT$43.90 Billion |
Liability Composition Analysis (2003–2024)
This chart breaks down Zhejiang Hisoar Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 002099 total asset value.
Liquidity & Leverage Metrics
Zhejiang Hisoar Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Zhejiang Hisoar Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.42 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Hisoar Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)
The table below shows the annual total liabilities of Zhejiang Hisoar Pharmaceutical Co Ltd from 2003 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥2.32 Billion ≈ $340.11 Million |
+21.16% |
| 2023-12-31 | CN¥1.92 Billion ≈ $280.72 Million |
-16.16% |
| 2022-12-31 | CN¥2.29 Billion ≈ $334.83 Million |
+20.03% |
| 2021-12-31 | CN¥1.91 Billion ≈ $278.95 Million |
+43.71% |
| 2020-12-31 | CN¥1.33 Billion ≈ $194.11 Million |
+29.70% |
| 2019-12-31 | CN¥1.02 Billion ≈ $149.66 Million |
-37.82% |
| 2018-12-31 | CN¥1.64 Billion ≈ $240.69 Million |
-29.25% |
| 2017-12-31 | CN¥2.32 Billion ≈ $340.21 Million |
+8.88% |
| 2016-12-31 | CN¥2.14 Billion ≈ $312.46 Million |
+69.73% |
| 2015-12-31 | CN¥1.26 Billion ≈ $184.09 Million |
+27.24% |
| 2014-12-31 | CN¥988.73 Million ≈ $144.68 Million |
-33.05% |
| 2013-12-31 | CN¥1.48 Billion ≈ $216.09 Million |
+25.15% |
| 2012-12-31 | CN¥1.18 Billion ≈ $172.67 Million |
+69.01% |
| 2011-12-31 | CN¥698.17 Million ≈ $102.16 Million |
+39.00% |
| 2010-12-31 | CN¥502.28 Million ≈ $73.50 Million |
+15.60% |
| 2009-12-31 | CN¥434.48 Million ≈ $63.58 Million |
-6.68% |
| 2008-12-31 | CN¥465.58 Million ≈ $68.13 Million |
+13.09% |
| 2007-12-31 | CN¥411.69 Million ≈ $60.24 Million |
+2.24% |
| 2006-12-31 | CN¥402.66 Million ≈ $58.92 Million |
+2.26% |
| 2005-12-31 | CN¥393.76 Million ≈ $57.62 Million |
+54.20% |
| 2004-12-31 | CN¥255.35 Million ≈ $37.37 Million |
-7.94% |
| 2003-12-31 | CN¥277.36 Million ≈ $40.59 Million |
-- |
About Zhejiang Hisoar Pharmaceutical Co Ltd
Zhejiang Hisoar Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products and dyes in China and internationally. The company offers antibiotics, cardiovascular, hypoglycemic, fine chemicals, formulations, intermediates, and other products. It also provides dyestuff, and intermediates of dyestuff and pigment; and manufactures environmental protection related equipment, medical… Read more